1. Layer-by-layer self-assembly coatings on strontium titanate nanotubes with antimicrobial and anti-inflammatory properties to prevent implant-related infections.
- Author
-
Guan J, Wang J, Jia F, Jiang W, Song L, Xie L, Yang H, Han P, Lin H, Wu Z, Zhang X, and Huang Y
- Subjects
- Mice, Animals, Humans, RAW 264.7 Cells, Human Umbilical Vein Endothelial Cells drug effects, Microbial Sensitivity Tests, Surface Properties, Tannins chemistry, Tannins pharmacology, Osteogenesis drug effects, Poloxamer chemistry, Poloxamer pharmacology, Cell Proliferation drug effects, Gentamicins pharmacology, Gentamicins chemistry, Particle Size, Titanium chemistry, Titanium pharmacology, Nanotubes chemistry, Strontium chemistry, Strontium pharmacology, Anti-Inflammatory Agents pharmacology, Anti-Inflammatory Agents chemistry, Staphylococcus aureus drug effects, Coated Materials, Biocompatible chemistry, Coated Materials, Biocompatible pharmacology, Escherichia coli drug effects, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents chemistry, Prostheses and Implants
- Abstract
One way to effectively address endophyte infection and loosening is the creation of multifunctional coatings that combine anti-inflammatory, antibacterial, and vascularized osteogenesis. This study started with the preparation of strontium-doped titanium dioxide nanotubes (STN) on the titanium surface. Next, tannic acid (TA), gentamicin sulfate (GS), and pluronic F127 (PF127) were successfully loaded into the STN via layer-by-layer self-assembly, resulting in the STN@TA-GS/PF composite coatings. The findings demonstrated the excellent hydrophilicity and bioactivity of the STN@TA-GS/PF coating. STN@TA-GS/PF inhibited E. coli and S. aureus in vitro to a degree of roughly 80.95 % and 92.45 %, respectively. Cellular investigations revealed that on the STN@TA-GS/PF surface, the immune-system-related RAW264.7, the vasculogenic HUVEC, and the osteogenic MC3T3-E1 showed good adhesion and proliferation activities. STN@TA-GS/PF may influence RAW264.7 polarization toward the M2-type and encourage MC3T3-E1 differentiation toward osteogenesis at the molecular level. Meanwhile, the STN@TA-GS/PF coating achieved effective removal of ROS within HUVEC and significantly promoted angiogenesis. In both infected and non-infected bone defect models, the STN@TA-GS/PF material demonstrated strong anti-inflammatory, antibacterial, and vascularization-promoting osteogenesis properties. In addition, STN@TA-GS/PF had good hemocompatibility and biosafety. The three-step process used in this study to modify the titanium surface for several purposes gave rise to a novel concept for the clinical design of antimicrobial coatings with immunomodulatory properties., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF